SEC Form 4 · accession 0001127602-19-007865

MERIDIAN BIOSCIENCE INC · VIVO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Feb 10, 2015

Accepted (ET)

Feb 25, 2019 · 9:36 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000794172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 10, 2015	P	33	$18.1998	A	3,013	D
Common Stock	May 11, 2015	P	32	$18.5148	A	3,045	D
Common Stock	Aug 10, 2015	P	32	$18.6911	A	3,077	D
Common Stock	Nov 23, 2015	P	32	$19.2658	A	3,109	D
Common Stock	Feb 12, 2016	P	32	$19.6196	A	3,141	D
Common Stock	May 16, 2016	P	33	$19.0604	A	3,174	D
Common Stock	Aug 15, 2016	P	32	$19.5009	A	6,206	D
Common Stock	Nov 28, 2016	P	38	$17.065	A	6,244	D
Common Stock	Feb 13, 2017	P	41	$12.9286	A	7,305	D
Common Stock	May 15, 2017	P	36	$14.8972	A	7,341	D
Common Stock	Aug 14, 2017	P	39	$13.938	A	7,380	D
Common Stock	Nov 28, 2017	P	38	$14.5607	A	7,418	D
Common Stock	Feb 13, 2018	P	39	$14.1311	A	7,457	D
Common Stock	May 15, 2018	P	40	$13.8794	A	7,497	D
Common Stock	Aug 16, 2018	P	38	$14.9125	A	7,535	D
Common Stock	Nov 28, 2018	P	31	$18.4216	A	8,566	D
Common Stock^F2	Feb 21, 2019	J	981	$0.00	D	0	D
Common Stock^F2	Feb 21, 2019	J	981	$0.00	A	9,547	D

No Table II lines on this filing.

F1Share purchases reflected on this Form were acquired via a Dividend Reinvestment Plan ("DRIP") beginning in February 2015 and ceasing in November 2018.
F2Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Common Stock holdings currently total 9,547.